Author: Eldric Moreland

post-image
Jan, 14 2026

Hip Labral Tears in Athletes: Diagnosis, Imaging, and Arthroscopy Recovery

Hip labral tears are common in athletes who perform repetitive hip rotations. Learn how MRA imaging detects tears, why arthroscopy is often needed, and what recovery really looks like for athletes trying to get back to play.
post-image
Jan, 13 2026

Thiazide Diuretics and Gout: What You Need to Know About Uric Acid Risks

Thiazide diuretics like hydrochlorothiazide can raise uric acid levels and trigger gout attacks, especially in people with risk factors. Learn how this happens, who's most at risk, and what alternatives exist.
post-image
Jan, 12 2026

Government Medication Assistance Programs by State: A 2026 Guide to State-Level Help for Prescription Costs

Learn how state and federal medication assistance programs can cut your prescription costs in 2026. Find out who qualifies, how to apply, and which programs offer the most help - with real examples and updated income limits.
post-image
Jan, 11 2026

Adverse Event Monitoring for Biosimilars: How Safety Surveillance Works in Practice

Biosimilars aren't generics-they need special safety tracking. Learn how adverse event monitoring works, why traceability matters, and what's changing in 2025 to keep patients safe.
post-image
Jan, 10 2026

How Pharmacists Drive Workplace Wellness by Promoting Generic Medications

Pharmacists play a vital role in workplace wellness by helping employees save money and stay healthy through generic medication promotion. Learn how they improve adherence, cut costs, and build trust.
post-image
Jan, 9 2026

Post-Surgical Pain Management: Multimodal Strategies to Reduce Opioid Use

Multimodal analgesia reduces opioid use after surgery by combining non-opioid medications and techniques like nerve blocks. Learn how this approach cuts pain, side effects, and hospital stays - and why it's now the standard of care.
post-image
Jan, 8 2026

Generic Manufacturer Profitability: Business Models and Sustainability in 2026

Generic drug manufacturers face collapsing margins due to price wars and complex market dynamics. Learn how top companies are shifting to complex generics and contract manufacturing to survive-and why the U.S. model is unsustainable.
post-image
Jan, 6 2026

Meglitinides and Hypoglycemia: Why Skipping Meals Is Dangerous with These Diabetes Drugs

Meglitinides like repaglinide and nateglinide help manage post-meal blood sugar in type 2 diabetes but carry a high risk of hypoglycemia if meals are skipped. Learn who's most at risk and how to use them safely.
post-image
Jan, 5 2026

Pancreatitis: Understanding Acute vs. Chronic and the Role of Nutrition in Recovery

Learn the key differences between acute and chronic pancreatitis, how nutrition impacts recovery, and what treatments-from enzyme therapy to lifestyle changes-can help you manage this serious condition.
post-image
Jan, 4 2026

FDA Serious Adverse Events Explained: What Patients Need to Know

Learn what the FDA really means by 'serious adverse event' - and why it's not the same as a severe side effect. Get clear, patient-focused facts on drug safety, reporting, and what to watch for.